Baicalin Suppressed Inflammatory Reaction by Decreasing Nuclear Factor-κB and Soluble Monocyte Chemoattractant Protein-1 in Hyperlipdemia Rat
DOI:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Aim To access the effect and mechanisms of baicalin on expression of nuclear factor-κB(NF-κB)and monocyte chemoattractant protein-1(MCP-1) in experimental atherosclerotic rat. Methods High fat forage and vitamin D3 was given by intragastric administration,the experimental group was given baicalein solution 20 mg/(kg·d) for four weeks.The blood lipid,plasma MCP-1 and immunohistochemistry detection of NF-κB on the renal glomerulus was performed. Results The total cholesterol(TC) and low density lipoprotein cholesterol(LDLC) in the serum of rats decreased in the experimental group to 30% baseline values treated by baicalein.The hyperlipidemia markedly raised the activities and contents of MCP-1 in plasma after modeling.Renal interstitium was hyperemic,the glomerular volume became extension,and NF-κB was markedly expressed in the podocyte and tubular epithelial cells than that of the control group(P><0.01). Conclusion Baicalein has the function of reducing the levels of LDL,reducing the NF-κB activating in glomerular cells,reducing the performance of MCP-1,and adjusting blood fat disorders and antiinflammatory.

    Reference
    Related
    Cited by
Get Citation

LI Xuan, YAN Rong-Hua, and PENG Jing. Baicalin Suppressed Inflammatory Reaction by Decreasing Nuclear Factor-κB and Soluble Monocyte Chemoattractant Protein-1 in Hyperlipdemia Rat[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2010,18(8):611-613.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:July 25,2010
  • Revised:August 16,2010
  • Adopted:
  • Online:
  • Published: